Bellevue Healthcare Trust plc

BBH:LSE

Bellevue Healthcare Trust plc

Actions
  • Price (GBX)135.20
  • Today's Change-0.80 / -0.59%
  • Shares traded1.58m
  • 1 Year change-4.65%
  • Beta0.9691
Data delayed at least 20 minutes, as of Feb 18 2026 16:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Bellevue Healthcare Trust plc grew revenues -- from -107.95m to 83.10m while net income improved from a loss of 121.04m to a gain of 73.73m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-10.14%
Return on equity-10.35%
Return on investment-10.35%
More ▼

Cash flow in GBPView more

In 2024, Bellevue Healthcare Trust plc increased its cash reserves by 146.94%, or 163.04m. Cash Flow from Investing totalled 360.45m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.28m for operations while cash used for financing totalled 191.56m.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.21
Tangible book value per share1.21
More ▼

Balance sheet in GBPView more

Bellevue Healthcare Trust plc has a strong Balance Sheet and has consistently grown its cash reserves over the last four years to total 273.99m.
Current ratio5.26
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in GBP

Year on year, growth in dividends per share fell -15.86% while earnings per share excluding extraordinary items rose 211.49%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.63%
Div growth rate (5 year)0.77%
Payout ratio (TTM)--
EPS growth(5 years)17.92
EPS (TTM) vs
TTM 1 year ago
-608.76
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.